---
figid: PMC5522257__oncotarget-08-41701-g003
figlink: /pmc/articles/PMC5522257/figure/F3/
number: F3
caption: In contrast, dynamin 3 has tumor suppressive role. Inhibition or depletion
  of the Akt/GSK3β signalling pathway will prevent the function of dynamin 1 in lung
  cancer cells. Moreover, inhibition of dynamin 2 interaction with Vav1 will stop
  the activation of Rac1, and a method that prevents phosphorylation of PDGFRα-PI3K/SHP-2
  will reduce the increased tumor growth and cancer cell invasion in certain types
  of cancer. Blockage of hypermethylation of DNM3 by some genetic approach or increase
  of expression of dynamin 3 protein will prevent the tumor development.
pmcid: PMC5522257
papertitle: Distinct functions of dynamin isoforms in tumorigenesis and their potential
  as therapeutic targets in cancer.
reftext: Jianghui Meng. Oncotarget. 2017 Jun 20;8(25):41701-41716.
pmc_ranked_result_index: '16562'
pathway_score: 0.940735
filename: oncotarget-08-41701-g003.jpg
figtitle: Distinct functions of dynamin isoforms in tumorigenesis and their potential
  as therapeutic targets in cancer
year: '2017'
organisms: Homo sapiens
ndex: c5b99505-dea7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5522257__oncotarget-08-41701-g003.html
  '@type': Dataset
  description: In contrast, dynamin 3 has tumor suppressive role. Inhibition or depletion
    of the Akt/GSK3β signalling pathway will prevent the function of dynamin 1 in
    lung cancer cells. Moreover, inhibition of dynamin 2 interaction with Vav1 will
    stop the activation of Rac1, and a method that prevents phosphorylation of PDGFRα-PI3K/SHP-2
    will reduce the increased tumor growth and cancer cell invasion in certain types
    of cancer. Blockage of hypermethylation of DNM3 by some genetic approach or increase
    of expression of dynamin 3 protein will prevent the tumor development.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - VAV1
  - AKT3
  - VAV2
  - PTPN11
  - VAV3
  - DNM3
  - KRAS
  - GSK3B
  - AKT1
genes:
- word: Akt/GSK3B
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Vav1
  symbol: VAV1
  source: hgnc_symbol
  hgnc_symbol: VAV1
  entrez: '7409'
- word: Akt/GSK3B
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Vav
  symbol: VAV
  source: bioentities_symbol
  hgnc_symbol: VAV2
  entrez: '7410'
- word: Vav
  symbol: VAV
  source: bioentities_symbol
  hgnc_symbol: VAV1
  entrez: '7409'
- word: PDGFRA-PI3K/SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Vav
  symbol: VAV
  source: bioentities_symbol
  hgnc_symbol: VAV3
  entrez: '10451'
- word: DNM3
  symbol: DNM3
  source: hgnc_symbol
  hgnc_symbol: DNM3
  entrez: '26052'
- word: K-RAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Akt/GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Akt/GSK3B
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals: []
diseases: []
figid_alias: PMC5522257__F3
redirect_from: /figures/PMC5522257__F3
figtype: Figure
---
